1000/1000
Hot
Most Recent
| Version | Summary | Created by | Modification | Content Size | Created at | Operation |
|---|---|---|---|---|---|---|
| 1 | Johannes W. Dietrich | -- | 511 | 2025-09-28 18:45:20 | | | |
| 2 | Johannes W. Dietrich | Meta information modification | 511 | 2025-09-28 18:47:11 | | | | |
| 3 | Catherine Yang | + 1 word(s) | 512 | 2025-09-29 02:39:20 | | |
Syndrome T, or SORSHOT, refers to persistent symptoms in patients affected by hypothyroidism who appear euthyroid by TSH levels. Seen in about 10% of hypothyroid patients, causes are unclear but likely include psychosomatic factors, inadequate treatment, autoimmunity, and neuropathy. Common symptoms are fatigue, heart-related issues, mood changes, weight gain, and pain. No standard treatment exists, but options may include combined hormone therapy, personalised dosing, and nutritional supplementation.
Syndrome T (aka SORSHOT) is the designation for the complex of continued symptoms and reduced quality of life in patients with hypothyroidism that seem to be sufficiently treated from a TSH-centric perspective. The affected suffer from persistent complaints despite being in a formally euthyroid condition (i.e. thyrotropin concentration is in its reference range) [1][2].
The term “syndrome T”, which is more common in Europe, traces back to “syndrome thyroiditis”, recognising a clustering of symptoms in autoimmune thyroiditis [3][4]. In the USA, the alternative term SORSHOT ("syndrome of residual symptoms of hypothyroidism on T4") is partly favoured, including hypothyroidism after thyroidectomy or radioiodine therapy [5]. On the other hand, the term “syndrome T” also includes latent autoimmune thyroid disease, i.e., autoimmune thyroiditis with preserved euthyroidism.
The prevalence of syndrome T is estimated to be between 5 and 15% of all patients with hypothyroidism or autoimmune thyroiditis [6]. Since about 5% of the population of developed countries suffers from hypothyroidism, this translates to a population prevalence of about 0.5%.
Up to now, the exact cause of the syndrome T remains unknown. It is probably one of the multifactorial symptom complexes. Potential reasons to be discussed include [6][7]:
Typical complaints include fatigue, tachycardia (both postural and at rest), palpitations, gastrointestinal symptoms, depression, anxiety, unstable weight (and, especially, weight gain), intolerance to both heat and cold, and diffuse, fibromyalgia-like pain [1][2][6].
Currently, a universal treatment program has not been established [9]. A significant subgroup of the affected may benefit from a combination therapy with levothyroxine (L-T4) and liothyronine (L-T3) [10], especially in cases of some polymorphic variants of the DIO2 gene, which encodes the type 2 deiodinase [11]. Other promising approaches include dosage of L-T4 based on reconstructing the setpoint of thyroid homeostasis with cybernetic methods (Thyroid SPOT), treatment of comorbidities, and immunomodulation with selenium and vitamin D [12].
Therefore, treatment of syndrome T requires a personalised approach [13].